Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

The primary analysis showed no between-group difference in CIPN symptoms. The secondary analysis indicated that CBD with THC could improve sensory impairment and might increase touch and vibration sense, although these findings require confirmation in a future, more fully powered study. Nonetheless, our results show that combination CBD/THC can be safely delivered to participants with CIPN and suggest that these cannabinoids should be further investigated for this indication.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-10-23
DOI
https://doi.org/10.3389/fonc.2025.1590168
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

Shoichi Shimamoto, Robin M. Ciocca, J Gary, Marisa C. Weiss et al.
Frontiers in Oncology
Cancer Treatment and Pharmacology
article

Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

Shoichi Shimamoto, Robin M. Ciocca, J Gary, Marisa C. Weiss, Lisa Saeed, Jennifer L. Sabol, Katherine M. DiGuilio, Katherine Aliano Ruiz, Paul Gilman, Jessica Burrell, Sarah Windawi, Sharon Larson, Julianne Hibbs, John H. Marks, Eric Zeger, Arezoo Ghaneie, Stephanie Kjelstrom, Muath Giaddui, Ebuwa Erebor, Gabrielle Bidas, Sara Jane Ward, Diana Martinez, David O. Holtz, Zonera Ali, Aarthi Shevade, Sam Meske
article en

Abstract

The primary analysis showed no between-group difference in CIPN symptoms. The secondary analysis indicated that CBD with THC could improve sensory impairment and might increase touch and vibration sense, although these findings require confirmation in a future, more fully powered study. Nonetheless, our results show that combination CBD/THC can be safely delivered to participants with CIPN and suggest that these cannabinoids should be further investigated for this indication.

Frontiers in OncologyVol. 15
Main Line Health (US), Texas Medical Center (US), Thomas Jefferson University (US), Lankenau Institute for Medical Research (US), Columbia University Irving Medical Center (US), Baylor University Medical Center (US), Lankenau Medical Center (US), New York Psychoanalytic Society and Institute (US), Baylor School (US), Breast Center (CH), Temple University (US)
National Institute on Drug Abuse, National Center for Complementary and Integrative Health
Openalex Percentile: Top 59%
Cancer Treatment and Pharmacology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.